Cargando…

Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study

BACKGROUND: The occurrence of KRAS mutations and their association with prognosis in metastatic colorectal cancer patients is not well documented in population-based studies. OBJECTIVES: To examine the feasibility of identifying archived colorectal cancer specimens, and through linkage with nationwi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montomoli, Jonathan, Hamilton-Dutoit, Stephen Jacques, Frøslev, Trine, Taylor, Aliki, Erichsen, Rune
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449754/ https://www.ncbi.nlm.nih.gov/pubmed/23028236 http://dx.doi.org/10.2147/CEG.S34725

Ejemplares similares

Positive predictive values of the coding for bisphosphonate therapy among cancer patients in the Danish National Patient Registry
por: Nielsson, Malene Schou, et al.
Publicado: (2012)

Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high
por: Lund, Jennifer L, et al.
Publicado: (2013)

Impact of preoperative serum albumin on 30-day mortality following surgery for colorectal cancer: a population-based cohort study
por: Montomoli, Jonathan, et al.
Publicado: (2015)

Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark
por: Grann, Anne Fia, et al.
Publicado: (2011)

Parental celiac disease and risk of asthma in offspring: a Danish nationwide cohort study
por: Andersen, Ane Birgitte Telén, et al.
Publicado: (2014)

Maternal inflammatory bowel disease and hypospadias in male offspring: a population-based study in Denmark
por: Andersen, Ane Birgitte Telén, et al.
Publicado: (2016)

Autism spectrum disorders in children of parents with inflammatory bowel disease – a nationwide cohort study in Denmark
por: Andersen, Ane Birgitte Telén, et al.
Publicado: (2014)

Parental Inflammatory Bowel Disease and Risk of Asthma in Offspring: A Nationwide Cohort Study in Denmark
por: Andersen, Ane Birgitte Telén, et al.
Publicado: (2013)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
por: Radanova, Maria, et al.
Publicado: (2023)

Feasibility of salivary DNA collection in a population-based case–control study: a pilot study of pediatric Crohn’s disease
por: Kappelman, Michael D, et al.
Publicado: (2018)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Positive predictive value of the International Classification of Diseases, 10th edition diagnosis codes for anemia caused by bleeding in the Danish National Registry of Patients
por: Zalfani, Jihen, et al.
Publicado: (2012)

Liver disease and mortality among patients with hip fracture: a population-based cohort study
por: Montomoli, Jonathan, et al.
Publicado: (2018)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Positive predictive value of the diagnosis coding for vitamin B12 deficiency anemia in the Danish National Patient Register
por: Ben Ghezala, Inès, et al.
Publicado: (2012)

Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
por: Lucchetti, Donatella, et al.
Publicado: (2021)

Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study
por: Montomoli, Jonathan, et al.
Publicado: (2013)

Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
por: Chen, Yu, et al.
Publicado: (2015)

KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location
por: Tabuso, M., et al.
Publicado: (2020)

The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
por: Sirisena, Nirmala Dushyanthi, et al.
Publicado: (2017)

Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank
por: Erichsen, Rune, et al.
Publicado: (2010)

The impact of chronic obstructive pulmonary disease on intensive care unit admission and 30-day mortality in patients undergoing colorectal cancer surgery: a Danish population-based cohort study
por: Platon, Anna Maria, et al.
Publicado: (2014)

Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
por: Gattenlöhner, S., et al.
Publicado: (2009)

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients
por: GUTIÉRREZ, CRISTINA, et al.
Publicado: (2013)

Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer
por: Takayama, Yuji, et al.
Publicado: (2018)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer—A Retrospective Study from a Tertiary-Level Center in Romania
por: Pîrvu, Edvina Elena, et al.
Publicado: (2023)

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review
por: Trojan, Jörg, et al.
Publicado: (2015)

The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
por: Poad, Heather, et al.
Publicado: (2022)

Survival of patients with primary liver cancer in central and northern Denmark, 1998–2009
por: Montomoli, Jonathan, et al.
Publicado: (2011)

Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018)

Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2017)

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
por: Shemirani, Atena Irani, et al.
Publicado: (2011)

Identifying Recurrences Among Non-Metastatic Colorectal Cancer Patients Using National Health Data Registries: Validation and Optimization of a Registry-Based Algorithm in a Modern Danish Cohort
por: Nors, Jesper, et al.
Publicado: (2023)

Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
por: Lin, Yu-Lin, et al.
Publicado: (2014)

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis
por: Carter, Gebra Cuyun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u4be08euc9rb9g5m2elgpm4qg2